Posts

Showing posts with the label over-the-counter drugs market research

The Over-The-Counter Drugs Market Is Gaining Major Traction With Glaxosmithkline Plc Receiving The U.S. Food And Drug Administration (FDA) Approval For Three Over-The-Counter (OTC) Drugs

Image
 Over-the-Counter Drugs are medications sold directly to the consumer without a need for a physician's prescription, rather than prescription drugs, which can only be provided to medical users possessing a valid prescription from a health care provider. They are generally accessible to anyone over the age of eighteen and can generally be purchased over-the-counter. Common over-the-counter drugs include aspirin, acetaminophen, ibuprofen, naproxen, and indomethacin. One of the key reasons behind the massive penetration of OTC drugs is product innovation. Pharmaceutical companies are focused on continuous research and development activities, in order to launch novel products. Recently, in January 2021, Hamdard Laboratories launched 12 OTC medicines that will help boost immunity. Similarly, in April 2021, Bal Pharmaca launched its first OTC product Eye Spa. Thus, factors can potentially augment growth of the over-the-counter drugs market. Another key factor governing the development ...